Holen Sie sich die Stockscreener-App
651.78
1.08%
7.40
Schlusskurs vom Vortag:
$644.38
Offen:
$653.51
24-Stunden-Volumen:
5.86M
Relative Volume:
0.33
Marktkapitalisierung:
$1.66T
Einnahmen:
$214.96B
Nettoeinkommen (Verlust:
$70.59B
KGV:
23.70
EPS:
27.5066
Netto-Cashflow:
$48.25B
1W Leistung:
+5.61%
1M Leistung:
+8.72%
6M Leistung:
-0.53%
1J Leistung:
-13.26%
1-Tages-Spanne:
$648.51
$664.24
1-Wochen-Bereich:
$609.74
$664.24
52-Wochen-Spanne:
$520.26
$790.80
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
651.70 | 1.64T | 214.96B | 70.59B | 48.25B | 27.51 |
GOOGL
Alphabet Inc
|
342.24 | 4.07T | 446.32B | 244.21B | 53.27B | 19.91 |
GOOG
Alphabet Inc
|
339.43 | 4.04T | 446.32B | 244.21B | 53.27B | 19.91 |
SPOT
Spotify Technology Sa
|
527.00 | 107.26B | 20.32B | 3.16B | 3.82B | 12.55 |
DASH
Doordash Inc
|
203.37 | 87.11B | 14.72B | 923.00M | 1.75B | 2.0994 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-27 | Bestätigt | Rosenblatt | Buy |
| 2026-08-27 | Bestätigt | Truist | Buy |
| 2026-07-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Fortgesetzt | Wedbush | Neutral |
| 2026-07-10 | Bestätigt | Citizens | Mkt Outperform |
| 2026-07-07 | Hochstufung | Erste Group | Hold → Buy |
| 2026-06-02 | Hochstufung | Arete | Neutral → Buy |
| 2026-05-20 | Bestätigt | Wells Fargo | Overweight |
| 2026-05-05 | Bestätigt | Mizuho | Outperform |
| 2026-04-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Bestätigt | Wolfe Research | Outperform |
| 2026-04-09 | Bestätigt | Rosenblatt | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Meta at $645: Recent Momentum Makes One Thing Very Clear - 24/7 Wall St.
Mark Zuckerberg’s $100-a-Month Muse Bet Signals Meta’s Desperate Pivot Away From Ads - 24/7 Wall St.
Dividend Roundup: Meta Platforms, Verizon, UnitedHealth Group, Coca-Cola, and more - Seeking Alpha
Feed to Feat: Can Meta Unlock the AI Agent Cash Machine? - MarketBeat
Meta Platforms stock gains as J.P. Morgan and others lift AI-driven price targets - ad-hoc-news.de
What the settlement left out: Meta can still collect data from kids - The Conversation
First Look: Oracle Surges on Cloud Growth; Meta Reverses AI Cuts - GuruFocus
Meta Platforms, Inc. (NASDAQ:META) to Issue Quarterly Dividend of $0.53 - MarketBeat
Meta declares $0.525 quarterly dividend - grafa.com
Does Meta Platforms (META) Still Trade At A Discount To Fair Value? - simplywall.st
Meta Platforms Insider Sold Shares Worth $3,301,175, According to a Recent SEC Filing - marketscreener.com
Meta Platforms Keeps Quarterly Dividend of $0.525 per Share, Payable Sept. 28 to Holders of Record as of Sept. 21 - marketscreener.com
Why Is Meta Platforms (META) Drawing Attention? - Kalkine Media
Andrew Tulloch Leaves Meta for Anthropic [2026] - shattered.io
META Looks 24.2% Undervalued on GF Value™ - GuruFocus
Meta Platforms stock heads into the open after a 6.6 percent jump - ad-hoc-news.de
Mark Zuckerberg's Meta Is Charging Consumers for a Personal AI Agent for the First Time. Here's What $20 and $100 a Month Could Add to Revenue. - The Motley Fool
Meta’s (META) Muse Launch Turns the AI Debate toward Subscription Economics - Yahoo Finance
Meta in talks with Seoul on social media restrictions for children - Japan Wire by Kyodo News
Meta Muse Launch Triggers Wall Street Upgrade Wave, Target Prices Reach as High as $830 - finance.biggo.com
Meta Platforms, Inc. Announces Quarterly Cash Dividend on Class A Common Stock and Class B Common Stock, Payable On September 28, 2026 - marketscreener.com
Meta’s $18 Billion Settlement Removes a Massive Risk, But May Reshape Teen Engagement - Yahoo Finance
Zuckerberg’s Special Treatment of Rogan Presented in Meta Trial - Bloomberg Law News
Meta platforms COO Javier Olivan sells $3.3m in shares - Investing.com
JPMorgan resets Meta stock price target for the rest of 2026 - thestreet.com
Meta declares quarterly dividend of $0.525 per share - Investing.com
Meta declares quarterly dividend of $0.525 per share By Investing.com - Investing.com UK
Meta Announces Quarterly Cash Dividend - Meta Investor Relations
Meta Platforms (NASDAQ: META) COO offloads 5,354 shares in planned sale - Stock Titan
Here's Why Meta Platforms (META) Fell More Than Broader Market - Yahoo Finance
New Zuckoff app detects nearby Meta 'perv glasses:' 'right to at least know that someone is recording' - New York Post
Portuguese group D3 sues Meta, TikTok and YouTube over addictive design - Reuters
Meta failed to curb anti-LGBTI hate on Facebook in Hungary, Amnesty International says - Jurist.org
Meta Platforms Options Spot-On: On September 10th, 750.84K Contracts Were Traded, With 3.51 Million Open Interest - Moomoo
Meta is asking some of its employees to become managers again in a new reorg - Business Insider
Meta tests out putting fact-checking in users’ hands across Latin AmericaTruth or Fake - France 24
Meta Added $100 Billion in One Day. A 350-Ad Scandal Arrived Hours Later. - 24/7 Wall St.
Latin America fact-check group asks Meta not to replace verification practice - France 24
Meta Shares Rise as Muse Cracks App Store's Top Three - TradingView
Meta Shares Slip After Star AI Researcher Andrew Tulloch Abruptly Exits - finance.biggo.com
Why Meta Platforms (NASDAQ:META) Bucked The Broader Tape This Session? - Kalkine Media
Cathie Wood's ARK Rotates Nearly $56 Million From Alphabet to Meta After Muse Debut - finance.biggo.com
JPMorgan Turns Bullish on Meta, Lifts Target to $820 on AI Agent Momentum - finance.biggo.com
Zuckerberg Wins Wednesday as Top 10 Billionaires Lose $40B in Net WorthMeta Platforms (NASDAQ:META) - Benzinga
Cloudflare Shares Extend Rally as Meta's Muse Agent Stokes Edge-Computing Optimism - finance.biggo.com
Andrew Tulloch, Meta’s star AI recruit, is leaving after less than a year - The Next Web
Computer History Museum Announces "Extended Reality: Visions of the Future" Exhibit - GlobeNewswire Inc.
Meta Buys Stilla.ai: What the Swedish AI Acquisition Means for META Stock - Yahoo Finance
Meta Platforms' Weak Trust Score Could Limit Muse Adoption, Oppenheimer Says - marketscreener.com
Meta Might Be Building AWS For AI Compute (NASDAQ:META) - Seeking Alpha
JPMorgan Lifts Meta to $820 as Muse Reaches Number Three - Yahoo Finance
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
Meta Platforms Inc-Aktie (META) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Sep 08 '26 |
Sale |
616.44 |
2,516 |
1,550,951 |
1,289 |
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):